Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
AHA Journals This Week | July 6, 2020
07/06/2020 | AHA Journals This Week July 6, 2020
STROKE | Editor's Picks | July 2020
07/06/2020 | Stroke Editor's Picks for July 2020
STROKE | Editor's Picks | June 2020
06/04/2020 | Stroke Editor's Picks for June 2020
Collaboration with LLNL shares COVID-19 research data
05/22/2020 | The American Heart Association is pleased to announced that our collaboration with Lawrence Livermore National Labs (LLNL) on the protein atlas developed through the AHA Center for Accelerated Discovery is being leveraged to help accelerate discovery of therapeutic antibodies or antiviral drugs for SARS-CoV-2, the virus that causes COVID-19.
CIRCULATION Editor's Picks | April/May 2020
05/19/2020 | CIRCULATON Editor's Picks for April/May 2020
QCOR 2020 Science News
05/15/2020 | Science News from Quality of Care and Outcomes Research (QCOR) 2020 Scientific Sessions | May, 15-16 2020 | Reston, VA
AHA, ACC redefine guideline processes
04/27/2020 | In a historic move, the AHA and ACC re-visited their 30-year partnership of jointly producing clinical practice guidelines for the cardiovascular community.
Circulation: Cardiovascular Imaging | Twitter Journal Club | April 30, 2020
04/21/2020 | Circulation: CV Imaging Twitter Journal Club Impact of Clinical Characteristics and Statins on Coronary Plaque Progression by Serial Computed Tomography Angiography
CIRCULATION Editor's Picks | March/April 2020
04/17/2020 | CIRCULATON Editor's Picks for March/April 2020
STROKE | Trending Topics | March 2020
04/17/2020 | Stroke Trending Topics for March 2020
Clinical Management of Stable Coronary Artery Disease in Patients With T2DM
04/13/2020 | The epidemic of type 2 diabetes mellitus (T2D), linked to the increased burden of obesity, is projected to affect over 600 million patients worldwide in the next 2 decades.